fda warning letters compounded semaglutide tirzepatide 2024 2025 Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly Drugmakers battle pharmacies over compounded

In a pre-specified secondary analysis of the SELECT trial, once-weekly subcutaneous semaglutide 2.4mg in patients with obesity was associated with a 22% reduction in the main 5-component kidney composite endpoint compared to patients on placebo.

Baar and Langer explore what GLP1 weight loss means for exercise, tendons, aging, and realworld obesity treatment.

*Always consult your healthcare provider before starting any supplement regimen.*

OpenAI and Anthropic are both partnering with private equity firms in a bid to deploy their AI products to more businesses.

Hims & Hers releases a one-year review of its weight loss program

Least-squares mean standard error changes from baseline to final heart rate were + 2.7 0.2, + 1.0 0.3, and + 3.0 0.4 bpm with exenatide QW, exenatide BID, and liraglutide, respectively, and 0.8 0.2 bpm with non-GLP-1RAs